Suppression and flare regimens of gonadotropin-releasing hormone agonist: Use in women with different basal gonadotropin values in an in vitro fertilization program

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 41, Issue 5, 1996, Pages 321-326

  Toth, Thomas L ^a   Awwad, Johnny T ^a   Veeck, Lucinda L ^b   Jones Jr , Howard W ^b   Muasher, Suheil J ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c The Jones Institute for Reproductive Medicine   (United States)

Author keywords

fertilization in vitro; gonadotropins

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; HYDROXYPROGESTERONE CAPROATE; LEUPRORELIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GONADOTROPIN BLOOD LEVEL; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PREGNANCY COMPLICATION; PREGNANCY RATE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; LEUPROLIDE; MENSTRUAL CYCLE; OVARY; PREGNANCY; PREGNANCY RATE; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES;

EID: 0029898766     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Porter RN, Smith W, Craft JL, et al: Induction of ovulation for in-vitro fertilization using busurelin and gonadotropins. Lancet 1984;2:1284-1286
2. Neveu S, Hedon B, Bringer J, et al: Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987; 47:639-643
3. Meldrum DR, Wisot A, Hamilton F, et al: Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989;51:455-459
4. Droesch K, Muasher SJ, Brzyski RG, et al: Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989;51:292-297
5. Fleming R, Coutts JRT: Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986;45:226-230
6. Frydman R, Belaisch-Allart J, Parneix I, et al: Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program. Fertil Steril 1988;50:471-475
7. Zorn J-R, Barata M, Brami C, et al: Ovarian stimulation for in-vitro fertilization combining administration of gonadotrophins and blockade of the pituitary with D-Trp6-LHRH microcapsules: Pilot studies with two protocols. Hum Reprod 1988;3:235-239
8. Garcia JE, Padilla SL, Bayati J, et al: Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: A better alternative for ovulation in in vitro fertilization. Fertil Steril 1990;53:302-305
9. Barriere P, Lopez P, Boiffard J-P, et al: Use of GnRH analogues in ovulation induction for in-vitro fertilisation: Benefit of a short administration regimen. J In Vitro Fertil Embryo Transf 1987;4:64-65
10. Acharya U, Small J, Randall J, et al: Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilization program. Fertil Steril 1992;57: 815-818
11. Lenton EA, Sexton L, Lee S, et al: Progressive changes in LH and FSH and LH:FSH ratio in women throughout reproductive life. Maturitas 1988;10:35-43
12. Muasher SJ, Oehninger S, Simonetti S, et al: The value of basal and/or stimulated sperm gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298-307
13. Scott RT, Toner JP, Muasher SJ, et al: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651-654
14. Tanbo T, Dale PO, Abyholm T, et al: Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/human menopausal gonadotropin-stimulated cycles for in vitro fertilization. Hum Reprod 1989;4:647-650
15. Toner JP, Philput CB, Jones GS, et al: Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-791
16. Ebrahim A, Rienhardt G, Morris S, et al: Follicle stimulating hormone levels on cycle day 3 predict ovulation stimulation response. J Assist Reprod Genet 1993;10:130-136
17. Muasher SJ, Garcia JE, Rosenwaks Z: The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization. Fertil Steril 1985;44:66-69
18. Veeck LL, Wortham JWE, Witmeyer J, et al: Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization. Fertil Steril 1983;39:594-602
19. Loumaye E, Vankrieken L, Depreester S, et al: Hormonal changes induced by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development. Fertil Steril 1989;51: 105-111
20. Tan S-L, Kingsland C, Campbell S, et al: The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810-814
21. San Roman GA, Surrey ES, Judd HJ, et al: A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril 1992;58:744-749
22. Brzyski RG, Muasher SJ, Droesch K, et al: Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment. Fertil Steril 1988;50:917-921
23. McNatty KP, Smith DM, Makris A, et al: The microenvironment of the human antral follicle: Interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 1979;49:851-860
24. Smitz J, Devroey P, Braeckmans P, et al: Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Hum Reprod 1987;2: 309-314
25. Antoine JN, Salat-Baroux J, Alvarez S, et al: Ovarian stimulation using human menopausal gonadotropins with or without LHRH analogues in a long protocol for in vitro fertilisation: A prospective randomized comparison. Hum Reprod 1990;5:565-969